Media

Aro Biotherapeutics Secures $41.5M Series B Financing 

Priothera – US FDA grants Orphan Drug Designation to mocravimod to improve the outcome of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with hematologic malignancies

Invitation to BONESUPPORT’s Capital Markets Day

Article with exploratory alkylator-refractory subgroup analysis from Oncopeptides’ OCEAN study observing longer PFS and OS in melflufen vs. pomalidomide published in European Journal of Haematology

Spruce Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate Updates

Oncopeptides selected to present additional data from OCEAN study at the American Society of Hematology meeting

Oncopeptides Chief Financial Officer Henrik Bergentoft takes office today

Carisma Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Aprea Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update

Oncopeptides publishes Q3 report 2023